The breast imaging market is expected to grow significantly during the forecast period (2018-2023). The breast imaging is the process of reproduction of breast’s form. It helps to identify breast abnormalities and diagnose them with imaging technologies. There are various breast imaging techniques used for the diagnostic procedure such as mammography, breast tomosynthesis, MRI, ultrasound, and galactography. The global breast imaging market is growing at a significant rate due to various factors such as increased incidences and prevalence of breast cancer and the growing geriatric population across the globe. In addition, increasing investment and funding in research and development activities of breast cancer diagnostics and government initiatives to raise awareness among the people to propel the growth of the market.
There are certain factors that act as barriers for the market growth such as high cost of imaging systems, side effects related to imaging, strict government regulations and lack of awareness among women about breast cancer in developing countries. However, emerging technologies for breast imaging, increasing demand for breast imaging from the Asian region, improving healthcare infrastructure and increasing spending on health care creates future opportunities for the growth of the market.
The market for breast imaging is segmented into two segments: ionizing breast technologies and non-ionizing breast technologies. Ionizing breast technologies is further diversified as analog mammography, 3D breast tomosynthesis, cone beam computed tomography, positron emission mammography, and molecular breast imaging. On the basis of non-ionizing breast technologies, the market is studied as breast MRI, breast ultrasound, optical imaging, and breast thermography. Among ionizing breast technologies, analog mammography is expected to hold the significant share in the market.
Geographically, the global breast imaging market is divided into North America, Europe, Asia Pacific and Rest of the world. Taking into consideration the North America region dominates the global market due to the presence of developed technology and healthcare infrastructure. Europe covers noteworthy market share with high initiatives in the field of research & development and spreading awareness among people. Asia Pacific region is anticipated to grow at a faster rate due to the increasing prevalence of breast cancer, the changing lifestyle of people, and developing healthcare infrastructure.
The companies contributing to the global market are Hologic Inc., GE Healthcare, Siemens Healthcare, Philips Healthcare, Aurora imaging technology Inc., AGFA Healthcare, Dillon technologies, CRM Naviscan, Koning Corporation, Dune medical devices, Planmeca Oy, and Shimadzu Corporation. These players are striving to maintain their potential share in the market. Increasing competition by improvements in technology and developments of new product lead to decrease cost of the product that enhances the market outcomes.
The market study of the breast imaging market is incorporated by extensive primary and secondary research. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.
Secondary sources include:
- Financial reports of companies involved in the market
- Authentic Public Databases such as American College of Radiology, Carol Milgard Breast Center and others.
- Whitepapers, research-papers, and news blogs
- Company websites and their product catalogue
- Supplier Websites such as Alibaba, Amazon for pricing analysis
The report is intended for drug manufacturers, healthcare provider, government organizations for overall market analysis, and competitive analysis. The report provides in-depth analysis of pricing, market size, intended quality of the product preferred by consumers and initial norms. The report also includes a patent analysis for breast cancer imaging. The report will be delivering insights into the market for better business decisions.
Global Breast imaging market is segmented on the basis of regional outlook and following segments:
1. Global Breast Imaging Market Research and Analysis, By Ionizing Breast Technologies
2. Global Breast Imaging Market Research and Analysis, By Non-Ionizing Breast Technologies
3. Global Breast Imaging Market Research and Analysis, By Region
The Report Covers
- Comprehensive research methodology of global breast imaging
- This report also includes a detailed and extensive market overview with key analyst insights.
- An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the global breast imaging market.
- Insights about market determinants which are stimulating the global breast imaging market.
- Detailed and extensive market segments with regional distribution of forecasted revenues.
- Extensive profiles and recent developments of market players.
1. Report Summary
1.1. Research Methods And Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
1.2.3. By Stakeholders
2. Market Overview And Insights
2.2. Analyst Insights & Current Market Trends
2.2.1. Key Findings
2.3.1. United States
2.3.2. European Union
2.3.5. Rest Of The World
2.4. Patent Analysis
3. Market Determinant
3.1.1. Increasing Incidences Of Breast Cancer
3.1.2. Growing Geriatric Population
3.1.3. Investment And Funding In R&D Of Breast Cancer Diagnostics
3.1.4. Government Initiatives To Raise Awareness Among People
3.2.1. High Cost Of Imaging Systems
3.2.2. Lack Of Awareness Among Women About Breast Cancer In Developing Countries
3.3.1. Emerging New Imaging Technologies
3.3.2. Increasing Demand For Breast Imaging From Asian Countries
3.3.3. Improving Healthcare Infrastructure And Rising Spending On Healthcare
4. Market Segmentation
4.1. By Ionizing Breast Imaging Technologies
4.1.1. Analog Mammography
4.1.2. 3D Breast Tomosynthesis
4.1.3. Cone Beam Computed Tomography (Cb-Ct)
4.1.4. Positron Emission Mammography (Pem)
4.1.5. Molecular Breast Imaging
4.2. By Non- Ionizing Breast Imaging Technologies
4.2.1. Breast Mri
4.2.2. Breast Ultrasound
4.2.3. Optical Imaging
4.2.4. Breast Thermography
5. Competitive Landscape
5.1. Key Market Strategies
5.2. Key Company Analysis
6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.3. Rest Of North America
6.2.1. United Kingdom
6.2.6. Rest Of Europe
6.3. Asia Pacific
6.4. Rest Of The World
7. Company Profiles
7.1. Aurora Imaging Technology Inc.
7.2. Agfa Healthcare Corporation
7.3. Bracco S.P.A.
7.4. Carestream Health, Inc.
7.5. Cmr Naviscan Corporation
7.6. Cook Medical Incorporated
7.7. Dilon Technologies, Inc.
7.8. Dune Medical Devices Ltd.
7.9. Fischer Medical Technologies Llc
7.10. Fujifilm Holdings Corporation
7.11. Ge Healthcare
7.12. Hitachi Medical System
7.13. Hologic Inc.
7.14. Koning Corporation
7.15. Medtronic Plc
7.16. Philips Healthcare
7.17. Planmeca Oy
7.18. Shimadzu Corporation
7.19. Siemens Healthineers
7.20. Sonocine Inc.
7.21. Terason Corporation
7.22. Toshiba Corporation
- Aurora Imaging Technology Inc.
- Agfa Healthcare Corporation
- Bracco S.P.A.
- Carestream Health, Inc.
- Cmr Naviscan Corporation
- Cook Medical Incorporated
- Dilon Technologies, Inc.
- Dune Medical Devices Ltd.
- Fischer Medical Technologies Llc
- Fujifilm Holdings Corporation
- Ge Healthcare
- Hitachi Medical System
- Hologic Inc.
- Koning Corporation
- Medtronic Plc
- Philips Healthcare
- Planmeca Oy
- Shimadzu Corporation
- Siemens Healthineers
- Sonocine Inc.
- Terason Corporation
- Toshiba Corporation